Page last updated: 2024-10-22

albuterol and Familial Periodic Paralysis

albuterol has been researched along with Familial Periodic Paralysis in 6 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research Excerpts

ExcerptRelevanceReference
"In fifteen patients with hyperkalaemic familial periodic paralysis, inhalation of salbutamol alleviated hyperkaleamia and paralysis precipitated by exercise or oral administration of potassium chloride."5.04Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol. ( Clausen, T; Wang, P, 1976)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clausen, T3
Wang, P3
Orskov, H2
Kristensen, O1
Hanna, MG1
Stewart, J1
Schapira, AH1
Wood, NW1
Morgan-Hughes, JA1
Murray, NM1
Harris, DM1
Dahl-Jørgensen, K1
Michalsen, H1

Trials

1 trial available for albuterol and Familial Periodic Paralysis

ArticleYear
Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol.
    Lancet (London, England), 1976, Jan-31, Volume: 1, Issue:7953

    Topics: Adolescent; Adult; Aerosols; Albuterol; Animals; Clinical Trials as Topic; Epinephrine; Humans; Hype

1976

Other Studies

5 other studies available for albuterol and Familial Periodic Paralysis

ArticleYear
Hyperkalemic periodic paralysis. Relationships between changes in plasma water, electrolytes, insulin and catecholamines during attacks.
    Scandinavian journal of clinical and laboratory investigation, 1980, Volume: 40, Issue:3

    Topics: Albuterol; Blood Glucose; Blood Proteins; Body Water; Catecholamines; Chlorides; Electrolytes; Gluca

1980
Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A).
    Journal of neurology, neurosurgery, and psychiatry, 1998, Volume: 65, Issue:2

    Topics: Adrenergic beta-Agonists; Adult; Albuterol; Chromosomes, Human, Pair 17; DNA Mutational Analysis; El

1998
Letter: Salbutamol in hyperkalaemic familial periodic paralysis.
    Lancet (London, England), 1976, Feb-21, Volume: 1, Issue:7956

    Topics: Albuterol; Humans; Hyperkalemia; Paralyses, Familial Periodic

1976
Adynamia episodica hereditaria. Treatment with salbutamol.
    Acta paediatrica Scandinavica, 1979, Volume: 68, Issue:4

    Topics: Administration, Oral; Adolescent; Aerosols; Albuterol; Child; Female; Humans; Male; Paralyses, Famil

1979
Salbutamol inhalations suppress attacks of hyperkalemia in familial periodic paralysis.
    Monographs in human genetics, 1978, Volume: 10

    Topics: Albuterol; Blood Glucose; Humans; Hyperkalemia; Insulin; Muscles; Paralyses, Familial Periodic

1978